Globeflex Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Globeflex Capital’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-103	Closed	-$1K	–	589
2016 Q3	$1K	Buy	+103	New	+$742	﹤0.01%	467
2014 Q2	–	Sell	-500	Closed	-$1K	–	754
2014 Q1	$1K	Buy	+500	New	+$1.75K	﹤0.01%	604

Other funds holding CEMI

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NJBEST

New Jersey Better Educational Savings Trust Trenton, New Jersey $62.2M AUM 2.58% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CPIM

Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Globeflex Capital's CEMI Position: Q4 2016 in Review

Globeflex Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2016, closing a stake of 103 shares — an estimated $1K sold.

Globeflex Capital first reported a position in CEMI in Q1 2014 and held it in 2 quarters. The position peaked at $1K in Q3 2016. 26 funds tracked by Wall St. Rank hold CEMI as of Q4 2016.

Globeflex Capital reported no remaining Chembio diagnostics, Inc. position as of Q4 2016 after selling out during the quarter.
Globeflex Capital sold 103 Chembio diagnostics, Inc. shares in Q4 2016, an estimated $1K.
Globeflex Capital first reported a position in Chembio diagnostics, Inc. in Q1 2014 and held it in 2 quarters.
Globeflex Capital's Chembio diagnostics, Inc. position peaked at $1K in Q3 2016.
26 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2016.

Based on Globeflex Capital's 13F filing for Q4 2016, filed 13 Feb 2017.